FindTrial
Sign In

Monitoring of brain oxygen and function (with a new device called as Near-infrared Spectroscopy) during liver transplant surgery

Near-infrared Spectroscopy (NIRS) Monitoring In Living Donor Liver Transplantation: A Prospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/02/040306
Enrollment
50
Registered
2022-02-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K77- Liver disorders in diseases classified elsewhere

Interventions

None listed

Sponsors

Institute of liver and biliary sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients undergoing living donor liver transplantion Age 18-60 years

Exclusion criteria

Exclusion criteria: Patient refusal Patient with recent history of AKI ( History of stroke, history of transient ischemic attack, neurodegenerative disorders. MMSE score of less than 24.

Design outcomes

Primary

MeasureTime frame
Effect of different stages of living donor liver transplantation on NIRS valueTimepoint: After extubation, 7 day, 1month—

Secondary

MeasureTime frame
correlation of NIRS values with postoperative cognitive dysfunctionTimepoint: Preoperative After extubation Day 7& 1 month post transplant—

Countries

India

Contacts

Public ContactDr Vaishali Agrawal

Institute of liver and biliary sciences

drsindwani25@gmail.com8728089898

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026